Biography
Dr. Suresh Ramalingam is the Executive Director of the Emory Winship Cancer Institute and a leading thoracic oncologist. While best known for his lung cancer research, he has significant expertise in mesothelioma treatment and clinical trial design for rare thoracic malignancies. Dr. Ramalingam has published over 400 papers and leads one of the Southeast's premier thoracic oncology programs, providing mesothelioma patients in the region with access to cutting-edge treatment options.
Education & Training
- Medical Degree — Madras Medical College (India) (Medicine)
- Residency — University of Alabama at Birmingham (Internal Medicine)
- Fellowship — University of Alabama at Birmingham (Hematology/Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
As a medical oncologist, Dr. Suresh Ramalingam focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
- American Board of Internal Medicine — Internal Medicine
Research Focus
Systemic therapy for thoracic malignancies including mesothelioma, lung cancer targeted therapy, and clinical trial leadership for rare thoracic cancers.
Treatment Center
Dr. Suresh Ramalingam practices at Emory Winship Cancer Institute in Atlanta, GA.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
Does Emory Winship treat mesothelioma?
Yes. Under Dr. Ramalingam's leadership, Emory Winship Cancer Institute has a thoracic oncology program that treats mesothelioma with chemotherapy, immunotherapy, and clinical trials, coordinated with thoracic surgery.